Abstract
Background: In the Systolic Blood Pressure Intervention Trial (SPRINT), patients with prior cardiovascular disease (CVD) at baseline experienced a smaller relative reduction in fatal or non-fatal CVD events with an intensive systolic blood pressure (SBP) goal <120 mmHg compared to a standard SBP
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
